Position in TNGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,075,923
+$16,075,923 QoQ
Shares Held
514,265
Ownership
0.305%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#56
of 247 holders
Holding Since
Mar 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Derivatives in TNGX
reported options exposure · as of Jun 30, 2026CallValue
$750,240
CallShares
24,000
PutValue
$1,700,544
PutShares
54,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. TNGX ranks #18 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in TNGX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,700,544 | 54,400 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $16,075,923 | 514,265 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $750,240 | 24,000 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $686,176 | 32,800 | Put | Defined | 2026-05-12 | |
| 2025-12-31 | $262,256 | 29,600 | Put | Defined | 2026-02-12 | |
| 2025-03-31 | $483,468 | 352,897 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $294,256 | 95,229 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $390,882 | 50,764 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $591,076 | 68,890 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $417,866 | 52,628 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $853,616 | 86,224 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $68,365 | 20,592 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $57,764 | 14,624 | Shares | Defined | 2023-05-16 | |
| 2022-03-31 | $247,532 | 32,656 | Shares | Defined | 2022-05-17 | |
| No filing history on record for this holder in this stock. | ||||||